Origin of the HIV-1 group O epidemic in western lowland gorillas

Significance Understanding emerging disease origins is important to gauge future human infection risks. This is particularly true for the various forms of the AIDS virus, HIV-1, which were transmitted to humans on four independent occasions. Previous studies identified chimpanzees in southern Camero...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 112; no. 11; pp. E1343 - E1352
Main Authors D’arc, Mirela, Ayouba, Ahidjo, Esteban, Amandine, Learn, Gerald H., Boué, Vanina, Liegeois, Florian, Etienne, Lucie, Tagg, Nikki, Leendertz, Fabian H., Boesch, Christophe, Madinda, Nadège F., Robbins, Martha M., Gray, Maryke, Cournil, Amandine, Ooms, Marcel, Letko, Michael, Simon, Viviana A., Sharp, Paul M., Hahn, Beatrice H., Delaporte, Eric, Ngole, Eitel Mpoudi, Peeters, Martine
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 17.03.2015
National Acad Sciences
SeriesPNAS Plus
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Significance Understanding emerging disease origins is important to gauge future human infection risks. This is particularly true for the various forms of the AIDS virus, HIV-1, which were transmitted to humans on four independent occasions. Previous studies identified chimpanzees in southern Cameroon as the source of the pandemic M group, as well as the geographically more restricted N group. Here, we show that the remaining two groups also emerged in southern Cameroon but had their origins in western lowland gorillas. Although group P has only been detected in two individuals, group O has spread extensively throughout west central Africa. Thus, both chimpanzees and gorillas harbor viruses that are capable of crossing the species barrier to humans and causing major disease outbreaks. HIV-1, the cause of AIDS, is composed of four phylogenetic lineages, groups M, N, O, and P, each of which resulted from an independent cross-species transmission event of simian immunodeficiency viruses (SIVs) infecting African apes. Although groups M and N have been traced to geographically distinct chimpanzee communities in southern Cameroon, the reservoirs of groups O and P remain unknown. Here, we screened fecal samples from western lowland ( n = 2,611), eastern lowland ( n = 103), and mountain ( n = 218) gorillas for gorilla SIV (SIVgor) antibodies and nucleic acids. Despite testing wild troops throughout southern Cameroon ( n = 14), northern Gabon ( n = 16), the Democratic Republic of Congo ( n = 2), and Uganda ( n = 1), SIVgor was identified at only four sites in southern Cameroon, with prevalences ranging from 0.8–22%. Amplification of partial and full-length SIVgor sequences revealed extensive genetic diversity, but all SIVgor strains were derived from a single lineage within the chimpanzee SIV (SIVcpz) radiation. Two fully sequenced gorilla viruses from southwestern Cameroon were very closely related to, and likely represent the source population of, HIV-1 group P. Most of the genome of a third SIVgor strain, from central Cameroon, was very closely related to HIV-1 group O, again pointing to gorillas as the immediate source. Functional analyses identified the cytidine deaminase APOBEC3G as a barrier for chimpanzee-to-gorilla, but not gorilla-to-human, virus transmission. These data indicate that HIV-1 group O, which spreads epidemically in west central Africa and is estimated to have infected around 100,000 people, originated by cross-species transmission from western lowland gorillas.
Bibliography:http://dx.doi.org/10.1073/pnas.1502022112
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 14
ObjectType-Article-1
ObjectType-Feature-2
content type line 23
PMCID: PMC4371950
1Present address: International Center for Infectiology Research, INSERM U1111 and Ecole Normale Supérieure de Lyon and Université Claude Bernard Lyon 1 and CNRS UMR 5308, 69364 Lyon, France.
Contributed by Beatrice H. Hahn, February 2, 2015 (sent for review December 16, 2014; reviewed by Catherine A. Brennan and Tony L. Goldberg)
Reviewers: C.A.B., Abbott Diagnostics; and T.L.G., University of Wisconsin.
Author contributions: M.D., A.A., P.M.S., B.H.H., E.D., E.M.N., and M.P. designed research; M.D., A.A., A.E., V.B., F.L., L.E., M.O., M.L., and V.A.S. performed research; V.B., F.L., N.T., F.H.L., C.B., N.F.M., M.M.R., M.G., and E.M.N. contributed new reagents/analytic tools; M.D., A.A., G.H.L., A.C., M.O., M.L., V.A.S., and M.P. analyzed data; and M.D., A.A., P.M.S., B.H.H., and M.P. wrote the paper.
ISSN:0027-8424
1091-6490
1091-6490
DOI:10.1073/pnas.1502022112